Search papers, labs, and topics across Lattice.
The study benchmarks Gosset, an AI platform with curated drug-asset annotations, against four frontier LLMs (Claude Opus 4.7, GPT 5.5, Gemini 3.1 Pro, Perplexity sonar-pro) on pharmaceutical pipeline discovery tasks. Gosset achieves 3.2x higher recall with perfect precision compared to the best LLM when identifying drugs for niche oncology/immunology targets. Integrating Gosset's curated index as a tool significantly improves the LLMs' performance, suggesting the value of specialized knowledge bases over generic web search.
Frontier LLMs are leaving 70% of relevant pharmaceutical assets undiscovered, a gap that can be largely closed by swapping generic web search for a curated index.
General-purpose LLMs with web search are increasingly used to scout the competitive landscape of pharmaceutical pipelines. We benchmark Gosset -- an AI platform with a chat interface backed by curated target-, modality-, and indication-level drug-asset annotations -- against four frontier systems with web access (Claude Opus 4.7, GPT 5.5, Gemini 3.1 Pro, Perplexity sonar-pro) on ten niche oncology/immunology targets where most of the pipeline lives in the long tail of preclinical and Asian-developed assets. All five systems receive the same natural-language query and the same JSON output schema. Across 10 targets Gosset returns 3.2x more verified drugs per query than the best frontier system, at perfect precision and 100% recall against the cross-system union of verified drugs. The same curated index is exposed as a Gosset MCP server that any frontier model can call as a tool, suggesting that each of these systems can close most of the recall gap by swapping generic web search for a curated index behind the same chat interface.
